Cannabis Law Report

JULY 28, 2021

The Company and Its Subsidiary KGK Science Have Also Completed the Pre-Qualification Audits of Its Canadian Facilities to Enable Clinical Trials in an Arrangement with Aleafia Health. The audits will enable KGK to conduct clinical trials in the areas of psychedelics and nutraceuticals, among other substances of study.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

Cannabis Law Report

JANUARY 27, 2022

The majority of industry-sponsored drugs in active clinical development for FXS are in Phase II, with two drugs in Phase III. The distribution of clinical trials across Phase I-IV indicates that the majority of trials for FXS have been in the early and midphases of development, with 77% of trials in Phase I-II, and only 23% in Phase III-IV.

Clinical Trials 52

Clinical Trials Therapy Cannabinoids Topical 52

MMJ Recs

APRIL 1, 2024

From oils and tinctures to capsules and topical creams, CBD is available in various forms to suit individual preferences and needs. Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Canna Care Docs

OCTOBER 3, 2023

Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

PrestoDoctor

OCTOBER 11, 2023

For years, the use of cannabis has been a controversial topic. These behaviors may include repetitive movements, specific routines or rituals, intense interests in certain topics, and a resistance to change. In recent years, there has been growing interest in exploring alternative therapies for individuals with ASD.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. It covers the pipeline drug profiles, including clinical and nonclinical stage products. 70+ key companies which are developing the therapies for Epilepsy.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

Cannabis Law Report

MAY 29, 2022

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

CannaTech

SEPTEMBER 23, 2019

NICE develop evidence-based guidelines on a wide range of health-related topics, including integrating novel and emerging therapies. Last week NICE released the first draft of their evidence-based guidelines, concluding it could not recommend CBMPs for routine use because of high cost and a dearth of clinical trial evidence.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

MAY 10, 2022

This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. Medicinal cannabis has been so effective I don’t even think about other therapies,” Rocky said. The findings were published today in Frontiers in Pharmacology. Now, I am able to function completely normally.”.

Medicine 52

Medicine Clinical Trials Sleep Data 52

FloridaMarijuana.net

OCTOBER 19, 2018

Some patients find success with pharmaceuticals and talk-therapy. There are a variety of therapy approaches and psychologies. In addition to these medical interventions, Medical marijuana may also be beneficial to clinically depressed patients. Depression can be treated several ways.

Marijuana 189

Marijuana Research and Development Patients Clinical Trials 189

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. 11 × 11. In 2017, the FDA designated MDMA a breakthrough therapy for PTSD.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

AUGUST 17, 2021

Key Topics Covered: 1.0 Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity. Most of the Mobile Medical Applications in Clinical Trials are Monitoring Symptoms that can Support Early Disease Diagnosis.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

OCTOBER 10, 2021

We at Cantourage share the belief that cannabis is a valuable medicine which until now has not gained enough attention as a therapy option. Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). Customized compensation package.

Clinical Trials 52

Clinical Trials Therapy Medicine Policy 52

Cannabis Law Report

JANUARY 19, 2022

With his extensive experience in Congress and as a policy advisor on topics including health, technology, and education, we are confident Congressman Moran will be a great asset to IGC especially at a time when we pursue Phase 2/3 human trials on IGC- AD1 on individuals that have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

Cannabis Law Report

JUNE 19, 2022

Creating this infrastructure helps establish a system of values that shapes our goals and focuses our mission in strategic ways – all important steps given that the topic is so new,” Davis said. Davis and Slot predicted that as things stand, these therapies could be federally approved in three to five years. “If

Education 52

Education Research and Development Therapy Clinical Trials 52

MMJ Recs

NOVEMBER 30, 2023

As the field of medical marijuana research continues to evolve, THC’s role in epilepsy management remains a topic of interest and further exploration. Clinical trials and studies are underway to examine the potential benefits and risks of MMJ as a treatment option for epilepsy. Image by Uwe Conrad from Pixabay.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Cannabis Law Report

JUNE 25, 2021

EMA also regulates and supervises the drug quality, check for the intended use of the drug and whether the drug is meeting the requirement of clinical trial. Increasing use of biologics and targeted therapies is acting as a restraint in the skin cancer drugs market. The targeted therapies drugs targets melanoma cells only.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

Cannabis Law Report

OCTOBER 22, 2021

Cannabis oil: TO Pharmaceuticals TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases. INM-755: InMed Pharmaceuticals INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. Research programme: cannabidiol-combination therapies. Key Players.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

TheAnswerPage

JANUARY 11, 2022

Consequently, most clinicians are not familiar with the modes of administration and the pharmacodynamics/ pharmacokinetics of each mode, drug interactions, the different medical marijuana products (pills, flower, tinctures, topicals, etc.), Who monitors their health and the long-term effects of the marijuana therapy?

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 8, 2021

cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinical trials. The second phase of research is now underway to identify promising cannabinoids for both human and pet drug therapies.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

Puff Puff Post

NOVEMBER 5, 2019

. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. About INM-755. SOURCE InMed Pharmaceuticals Inc.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

FloridaMarijuana.net

AUGUST 13, 2018

Medications can be used along with therapy. The article described how “the most comprehensive research review ever done on the topic found that marijuana can help battle depression, anxiety, post-traumatic stress disorder, and even addictions to alcohol and painkillers.”

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials 52

Clinical Trials Events Medicine Therapy 52

MMJ Recs

DECEMBER 28, 2023

Additionally, the method of consumption, whether through inhalation, ingestion, or topical application, can influence the onset and duration of relief. The potential mood-regulating properties of cannabis have garnered attention as researchers explore alternative therapies.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Greencamp

FEBRUARY 2, 2019

These medications are combined in what’s known as HAART (highly active antiretroviral therapy). Even though these pharmaceuticals slow down the progression and lessen the quantity of the virus in a patient’s body, many sufferers experience severe pain from antiretroviral therapy. Cannabis as a palliative aid for HIV patients.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

OCTOBER 18, 2021

TO Pharma is developing next-generation cannabinoid therapies for debilitating diseases. INM-755 is a cannabinol topical cream under development for the treatment of epidermolysis bullosa. INM-755 cream for EB is the first, and currently the only, cannabinol formulation being tested in clinical trials as a therapeutic product.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Miss Marijuana

MAY 13, 2020

Topicals – These are a common way to use CBD for skin conditions or joint/pain issues. If you’re worried about taking too much, just know that clinical trials have prescribed CBD doses up to 1,200 mg daily for months without observing any serious side effects. Topical or inhaled products help minimize this interaction.

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

The Joint Blog

APRIL 22, 2022

There are multiple ways to ingest this oil; one can apply it topically, consume it through smoke inhalation or in the form of edible. Consumption of CBD through smoke inhalation or ingestion is beneficial for treating widespread pain, while topical application is recommended for alleviating pain from a specific area.

Oil 26

Oil CBD Topical Clinical Trials 26

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

SEPTEMBER 10, 2019

Upcoming studies will determine the effectiveness of psilocybin as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa and alcohol use in people with major depression. . Psychedelic Research News.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States.

Law 52

Law Programs Therapy Education 52

The Cannigma

DECEMBER 12, 2022

Clinical research: Today many scientists are researching the medicinal value of these mushrooms. The results are so compelling that the FDA has categorized magic mushrooms as a “breakthrough therapy” for depression, and is committed to fast tracking its approval. As such, there have been numerous clinical trials using ketamine.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

SEPTEMBER 20, 2021

We believe VRP324 is the first step toward building our neurological disorder therapy pipeline, expanding the use of our novel delivery platform technologies to multiple categories of neurology,” said Anthony P. Food and Drug Administration’s review. “We Mack, Chairman and CEO of Virpax.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 24, 2019

Future studies will explore psilocybin’s effectiveness as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa, and alcohol use in people with major depression. Participate in Our Studies.

Therapy 59

Therapy Treatment Medicine Clinical Trials 59

The Cannigma

JUNE 24, 2021

Many turn to cannabis for relaxation, alongside this natural therapy, though some people find that if they have consumed THC, the intoxicating effects can be too distracting when trying to meditate. There is a truly bewildering variety of cannabis products today, but many of them fall under three categories: inhalation, oral, and topical.

CBD 75

CBD Microdosing Edibles Sleep 75